---
title: "Haisen Pharm released its performance for the first three quarters, with a net profit attributable to the parent company of 88.2096 million yuan, an increase of 1.45%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262011146.md"
description: "Haisen Pharm released its Q3 2025 report, with operating revenue for the first three quarters at 359 million yuan, a year-on-year increase of 12.13%. The net profit attributable to the parent company was 88.2096 million yuan, a year-on-year increase of 1.45%. The net profit after deducting non-recurring gains and losses was 84.758 million yuan, a year-on-year decrease of 1.56%. The basic earnings per share were 0.59 yuan"
datetime: "2025-10-21T08:58:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262011146.md)
  - [en](https://longbridge.com/en/news/262011146.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262011146.md)
generator: "portal-rs"
---

# Haisen Pharm released its performance for the first three quarters, with a net profit attributable to the parent company of 88.2096 million yuan, an increase of 1.45%

According to the Zhitong Finance APP, Haisen Pharm (001367.SZ) released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 359 million yuan, a year-on-year increase of 12.13%. The net profit attributable to shareholders of the listed company was 88.2096 million yuan, a year-on-year increase of 1.45%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 84.758 million yuan, a year-on-year decrease of 1.56%. The basic earnings per share were 0.59 yuan

### Related Stocks

- [001367.CN](https://longbridge.com/en/quote/001367.CN.md)

## Related News & Research

- [Trump’s Bond Buyback Push Puts Kevin Warsh in a Tough Spot — Peter Schiff Says Treasury ‘Pulled the Rug Out From Under’](https://longbridge.com/en/news/296615127.md)
- [Negative Link Announces Global Expansion and Next Phase of Growth](https://longbridge.com/en/news/296644416.md)
- [Alibaba’s AI Spending Spree Intensifies — Surprise Stock Sale Has Analysts Asking Why](https://longbridge.com/en/news/296767766.md)
- [Promise Analyzes Telehealth Licensing Rules as Compact Hits Record 3,633 Licenses in a Month](https://longbridge.com/en/news/296635882.md)
- [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**